Baumgart Leigh A, Postula Kristen J Vogel, Knaus William A
Center for Biomedical Research Informatics (CBRI), NorthShore University HealthSystem, NorthShore University HealthSystem Research Institute, 1001 University Place, Evanston, IL, 60201, USA.
Fam Cancer. 2016 Apr;15(2):331-9. doi: 10.1007/s10689-015-9863-3.
Personal and family health histories remain important independent risk factors for cancer; however they are currently not being well collected or used effectively. Health Heritage was designed to address this need. The purpose of this study was to validate the ability of Health Heritage to identify patients appropriate for further genetic evaluation and to accurately stratify cancer risk. A retrospective chart review was conducted on 100 random patients seen at an adult genetics clinic presenting with concern for an inherited predisposition to cancer. Relevant personal and family history obtained from the patients' medical records was entered into Health Heritage. Recommendations by Health Heritage were compared to national guidelines of eligibility for genetic evaluation. Agreement between Health Heritage referral for genetic evaluation and guideline eligibility for genetic evaluation was 97% (sensitivity 98% and specificity 88%). Risk stratification for cancer was also compared between Health Heritage and those documented by a geneticist. For patients at increased risk for breast, ovarian, or colorectal cancer as determined by the geneticist, risk stratification by Health Heritage agreed 90, 93, and 75%, respectively. Discordances in risk stratification were attributed to both complex situations better handled by the geneticist and Health Heritage's adherence to incorporating all information into its algorithms. Health Heritage is a clinically valid tool to identify patients appropriate for further genetic evaluation and to encourage them to confirm the assessment and management recommendations with cancer genetic experts. Health Heritage also provides an estimate of cancer risk that is complementary to a genetics team.
个人和家族健康史仍然是重要的独立癌症风险因素;然而,目前它们并未得到充分收集或有效利用。健康传承(Health Heritage)旨在满足这一需求。本研究的目的是验证健康传承识别适合进一步基因评估的患者并准确分层癌症风险的能力。对一家成人遗传学诊所随机抽取的100名担心有遗传性癌症易感性的患者进行了回顾性病历审查。从患者病历中获取的相关个人和家族史信息被录入健康传承。将健康传承的建议与基因评估资格的国家指南进行比较。健康传承推荐进行基因评估与指南规定的基因评估资格之间的一致性为97%(敏感性98%,特异性88%)。还比较了健康传承与遗传学家记录的癌症风险分层情况。对于遗传学家确定的乳腺癌、卵巢癌或结直肠癌风险增加的患者,健康传承的风险分层分别有90%、93%和75%的一致性。风险分层的不一致既归因于遗传学家能更好处理的复杂情况,也归因于健康传承坚持将所有信息纳入其算法。健康传承是一种临床有效的工具,可识别适合进一步基因评估的患者,并鼓励他们与癌症基因专家确认评估和管理建议。健康传承还提供了与基因团队互补的癌症风险估计。